Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
26S proteasome non-ATPase regulatory subunit 3 (PSMD3) is a protein component of the 19S regulatory particle of the 26S proteasome, a multi-protein complex that mediates ATP-dependent degradation of ubiquitinated proteins in the cytosol and nucleus. PSMD3 plays an essential role in cellular protein homeostasis, cell cycle progression, apoptosis, and DNA damage repair, and is involved in the regulation of immune and inflammatory responses through its effects on MHC class I peptide processing and immune cell traits. Dysregulation of PSMD3 expression and activity is associated with several diseases, notably multiple cancers (such as breast cancer and chronic myeloid leukemia), where it impacts disease progression, drug resistance, and prognosis. While selective inhibitors for PSMD3 are not available, it is targeted indirectly by general proteasome inhibitors, which are used therapeutically in certain malignancies.
Inhibition of proteasomal protein degradation; Induction of apoptosis via accumulation of misfolded proteins and inhibition of survival signals; Sensitization to chemotherapeutic agents by impairment of degradation of key regulatory proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 26S proteasome non-ATPase regulatory subunit 3 (PSMD3).